Operations & Compliance
Corporate, regulatory, and counterparty reference.
Hong Kong corporate registration, operating model, quality and regulatory framework coverage, counterparty diligence procedure, documentation policy, and insurance cover.
01 · Corporate
Corporate registration.
The entity counterparties contract with. Beneficial-ownership disclosure and corporate-identity documentation available to verified reviewers on request, under NDA.
- Registered name
- Motark Enterprise Limited (摩達企業有限公司)
- Hong Kong CR
- 2338553
- Business registration
- 65775040
- Incorporated
- 4 February 2016
- Registered office
- Unit J, 9/F., King Palace Plaza, 55 King Yip Street, Kwun Tong, Kowloon, Hong Kong
- Banking jurisdiction
- Hong Kong (HKMA-regulated tier)
- Lab partner
- Murray-Brown Laboratories — Northglenn, CO
- Scope
- ISO 17025 · heavy metals · microbial · pesticide residues
02 · Operating model
Operating model.
Motark operates an asset-light, partner-network model. We do not own primary processing or analytical facilities directly. Capabilities are accessed through long-term contractual relationships with vetted partner laboratories, contract manufacturers, and cooperatives direct with growers across six sourcing regions.
01
Capital efficiency without quality compromise
Partner facilities operate at scale we could not match independently. Each is selected for its specific specialisation — pre-processing in Thailand and Fiji, extraction in India, ISO 17025 analytical work in EU and US labs, and fermentation in Southern Africa.
02
Multi-jurisdictional regulatory coverage
Operating through partner organisations in multiple jurisdictions gives our counterparties a structural advantage: documentation packages can be assembled to FDA, EFSA, TGA, HKMA, or ASEAN standards from the partner with the relevant local approval, rather than re-engineering from a single base.
03
Speed to specification
Custom extraction briefs that would require capacity expansion at an integrated manufacturer typically reach feasibility within two weeks through our partner network. Pilot batches in 6–10 weeks; commercial supply in 12–20 depending on jurisdiction.
03 · Quality systems
Certifications and standards.
Quality posture is operated through partner facilities — each carries the relevant certification per its specific scope of work. Motark coordinates the certification matrix at the counterparty level. Underlying audit reports are available to verified reviewers.
GMP-aligned operations
- Issuer
- Per partner facility — WHO-aligned and ICH Q7
- Scope
- All partner extraction, processing, and packaging operations
Quality Management Systems
- Issuer
- Accredited certification bodies (per partner)
- Scope
- Quality management at processing partners
Hazard Analysis and Critical Control Points
- Issuer
- Per partner facility
- Scope
- Food-grade extract operations
Analytical laboratory competence
- Issuer
- Accredited third-party laboratories (EU and US)
- Scope
- Per-batch analytical verification — heavy metals, pesticide residues, microbial, assay
Food Safety Management
- Issuer
- Per partner facility (where food-grade)
- Scope
- Food-grade extract operations
Good Agricultural and Collection Practices
- Issuer
- WHO-aligned, verified at intake
- Scope
- Origin sourcing operations
Named analytical partners
Per-batch testing laboratories.
Independent, accredited third-party laboratories engaged for per-batch analytical work. Underlying accreditation certificates and current scope documents available to verified reviewers on request.
Accreditation
ISO/IEC 17025:2017 — annually audited. CDPHE certifications: Hemp Metals, Hemp Microbials, Drinking Water Microbiology. Third-party proficiency-testing programmes: AOAC, LGC, NSI, Phenova, NIST.
Motark scope
Heavy metals, pesticide residues, microbial profiling, and regulatory dossier support.
Accreditation
A2LA-accredited ISO/IEC 17025 — chemical analysis and microbiological analysis on food products.
Motark scope
Identity verification, contaminants, and pathogen screening.
Accreditation
ISO/IEC 17025:2017 — accredited by Perry Johnson Laboratory Accreditation (PJLA). Current status verifiable on the PJLA accredited-organisation register.
Motark scope
Botanical-specific HPLC/UHPLC and GC-MS — kavalactones, bacosides, mesembrine-type alkaloids, and related botanical actives.
Accreditation status is verifiable directly with each issuing body. Additional partner laboratories engaged on a per-jurisdiction basis are disclosed to verified counterparties on request.
04 · Regulatory
Markets in active supply.
Motark supplies into these jurisdictions through its partner network. Documentation packages are structured to each importer's local requirements and made available to verified counterparties on request.
Market
United States
Framework
FDA — Dietary Supplement Health & Education Act
Motark posture
NDI notification framework where applicable. Documentation packages structured for 21 CFR §111 compliance.
Market
European Union
Framework
EFSA — Regulation (EU) 2015/2283 (Novel Food)
Motark posture
Compounds with novel-food status reviewed per partner-specific submissions; counterparty advised pre-supply.
Market
Australia
Framework
TGA — Therapeutic Goods Administration
Motark posture
Listed-medicine ingredient framework; AUST L documentation packages available on request.
Market
Hong Kong
Framework
HKMA · Centre for Food Safety
Motark posture
Banking and counterparty workflow aligned to HKMA expectations. Food-grade extract framework via CFS.
Market
ASEAN
Framework
Harmonised ASEAN traditional medicine framework
Motark posture
Per-jurisdiction documentation; regional supply contracts adapted to importer's local requirements.
05 · AML / KYC posture
Counterparty diligence procedure.
Some compounds in Motark's register carry jurisdictional sensitivity. The intake workflow below documents how we vet counterparties before any engagement and how that hygiene supports our banking relationships.
Counterparty verification — all engagements
Business email verification, registered organisation lookup, and intended-use declaration before any engagement. This is the baseline for sample shipments and document releases.
Bank-led KYC and sanctions screening — commercial engagements
The foundation of a commercial supply contract or licensing arrangement. Counterparty information — including beneficial-ownership disclosure — is collected and provided to our banking partner to support inbound payment clearance and the bank's formal KYC. Sanctions and PEP screening (OFAC, UK HMT, EU consolidated, HKMA) sits with the bank as standard banking practice.
Source-of-funds documentation — high-value commercial
For supply contracts above HKD 1m or for licensing arrangements: source-of-funds documentation requested from the counterparty per banking-partner guidance and provided to the bank for compliance review.
Banking partner alignment
Counterparty workflow designed in consultation with our banking partners. Material changes to risk classification or jurisdictional exposure trigger pre-engagement review.
06 · Documentation
Documentation policy.
Uniform across compounds and counterparties. Records retained on Motark systems as per regulatory guidance.
- Certificate of Analysis (COA)
- Issued per batch, retained 7 years
- Heavy metals report
- Per batch — Pb, As, Cd, Hg
- Pesticide residue report
- Per batch — USP <565> / EU MRL panels
- Microbial testing report
- Per batch — TPC, Y&M, E. coli, Salmonella
- Stability data
- On request, per compound and packaging
- Country of origin certificate
- Per consignment, partner-issued
- Material Safety Data Sheet (MSDS)
- Per compound, current revision
- Regulatory dossier
- Available on request — verified counterparties only
- AML/KYC counterparty documentation
- Compiled on request — banking and institutional reviewers
For institutional reviewers
Diligence documents on request.
Tell us what you need — registration, certifications, AML/KYC workflow detail, insurance certificates, or historical audit summaries — and we'll supply the relevant documents to verified reviewers.